LW

Lifeway Foods, Inc.

LWAYConsumer DefensiveNASDAQ

Packaged Foods · Last scanned Sep 8, 2026

PriceMA150MA200
Loading chart…
End-of-day data · ScananceOpen live chart on TradingView ↗
Indicator snapshot · Today
Premium
Today's indicator reading is locked

Free plan shows historical signals only. Upgrade to see this ticker's current MA150, MA200, RSI, and MACD readings.

Upgrade to see today →
Financials · Annual
Revenue
$212.5M
+13.7% YoY
Net Income
$13.9M
+53.6% YoY
EBITDA
$23.7M
+36.0% YoY
Free Cash Flow
-$32.2M

Scan Results

Daily timeframe
4 recent days hidden. Fresh signals are a Premium featureUpgrade →
DateIndicatorDetails
Sep 3 MACD Positive CrossoverHistogram +0.0539, positive momentum
Sep 2 MACD Positive CrossoverHistogram +0.0167, positive momentum
About Lifeway Foods, Inc.

Lifeway Foods, Inc. produces and markets probiotic-based products in North America. At a $377.8M market cap, Lifeway Foods, Inc. ranks as a small-cap company within consumer defensive. The company's primary product is drinkable kefir, a cultured dairy product in various organic and non-organic sizes, flavors, and milk types.

Where LWAY stands vs its 150-day and 200-day moving averages

As of the September 3, 2026 close, LWAY finished 3.93% above its 150-day moving average ($25.20) and 6.20% above its 200-day moving average ($24.66). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.

Is LWAY overbought or oversold?

At the September 3, 2026 close, LWAY's RSI(14) was 61.7, in neutral territory (between 30 and 70). The MACD histogram was positive, so short-term momentum leaned bullish at that close. These readings are historical, refresh daily after market close, and are not investment advice.

Key stats
Market Cap$377.8M
P/E (TTM)36.25
Fwd P/E18.53
EPS$0.69
Beta0.44
52W Change-23.1%
ROE13.3%
Analysis

Lifeway Foods, Inc. carries $22.5M in total debt against $7.1M in cash reserves — debt is roughly 3.2x the cash position. Managing this leverage effectively will be important for long-term financial stability. Free cash flow is running at -$32.2M, which bears watching. Negative free cash flow can be acceptable during heavy investment periods but needs to improve over time. ROE of 13.3% points to decent capital efficiency, indicating how much profit the company produces per dollar of shareholder equity. An ROA of 8.5% suggests reasonable efficiency in deploying the company's asset base. Revenue has grown from $141.6M (2022) to $212.5M (2025), reflecting a 50% increase over the period.

LWAY's low beta indicates it tends to be less volatile than the broader market, which may suit investors seeking more stable price behavior. The company is burning cash at the operating level, which is not unusual for growth-phase companies but adds risk if it persists. No single metric tells the full story. Reviewing LWAY's risk profile alongside its fundamentals and technical indicators provides a more complete picture.

Links
More Consumer Defensive stocks
Browse all stocks →
Not financial advice. Scanance shows end-of-day technical indicators (not real-time prices) for information only. Results can be wrong; past performance does not guarantee future results.PrivacyTerms